Yvonne Nartey1, Philip C Hill, Kwabena Amo-Antwi, Kofi M Nyarko, Joel Yarney, Brian Cox. 1. *Hugh Adam Cancer Epidemiology Unit and †Centre for International Health, University of Otago, Dunedin, New Zealand; and ‡Department of Obstetrics and Gynecology, Komfo Anokye Teaching Hospital, Kumasi; and §Disease Control and Prevention Department, Ghana Health Service; and ∥National Centre for Radiotherapy and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
Abstract
: Cervical cancer is one of the most common cancers among women worldwide, and more than 85% of the disease occurs in low- and middle-income countries. Although it ranks as the most common cancer in Ghanaian women, there are no data available on cervical cancer survival. METHODS: Information on women with a diagnosis of cervical cancer from 2010 to 2013 was collected from the Komfo Anokye and Korle-Bu Teaching Hospitals through review of paper-based and electronic medical records (including pathology records) at the oncology units and the departments of obstetrics and gynecology. Telephone interviews were conducted with patients and relatives to gather further information. Data were recorded using a standardized questionnaire and analyzed using summary statistics. RESULTS: Information for 821 women was available for the survival analysis. Of these, 497 (60.5%) died during follow-up. At 3 years after diagnosis, survival was 39%. Survival was lowest in women with stage IV disease. Women with squamous cell carcinoma had a survival advantage over those with adenocarcinoma. Furthermore, women who received surgery, radiotherapy, and chemotherapy had better survival than did women with other forms of treatment. CONCLUSIONS: In conclusion, cervical cancer survival is low in Ghana and is likely to be improved if a greater proportion of the disease is detected early. Improving knowledge of the disease for early diagnosis, reducing financial barriers, and greater organization of health care delivery are likely to improve survival from cervical cancer in Ghana.
: Cervical cancer is one of the most common cancers among women worldwide, and more than 85% of the disease occurs in low- and middle-income countries. Although it ranks as the most common cancer in Ghanaian women, there are no data available on cervical cancer survival. METHODS: Information on women with a diagnosis of cervical cancer from 2010 to 2013 was collected from the Komfo Anokye and Korle-Bu Teaching Hospitals through review of paper-based and electronic medical records (including pathology records) at the oncology units and the departments of obstetrics and gynecology. Telephone interviews were conducted with patients and relatives to gather further information. Data were recorded using a standardized questionnaire and analyzed using summary statistics. RESULTS: Information for 821 women was available for the survival analysis. Of these, 497 (60.5%) died during follow-up. At 3 years after diagnosis, survival was 39%. Survival was lowest in women with stage IV disease. Women with squamous cell carcinoma had a survival advantage over those with adenocarcinoma. Furthermore, women who received surgery, radiotherapy, and chemotherapy had better survival than did women with other forms of treatment. CONCLUSIONS: In conclusion, cervical cancer survival is low in Ghana and is likely to be improved if a greater proportion of the disease is detected early. Improving knowledge of the disease for early diagnosis, reducing financial barriers, and greater organization of health care delivery are likely to improve survival from cervical cancer in Ghana.
Authors: Kwabena Amo-Antwi; Ramatu Agambire; Thomas O Konney; Samuel B Nguah; Edward T Dassah; Yvonne Nartey; Adu Appiah-Kubi; Augustine Tawiah; Elliot K Tannor; Amponsah Peprah; Mavis Bobie Ansah; Daniel Sam; Patrick K Akakpo; Frank Ankobea; Rex M Djokoto; Maame Y K Idun; Henry S Opare-Addo; Baafour K Opoku; Alexander T Odoi; Carolyn Johnston Journal: PLoS One Date: 2022-06-03 Impact factor: 3.752
Authors: Yvonne Nartey; Philip Hill; Kwabena Amo-Antwi; Richard Asmah; Kofi Nyarko; Joel Yarney; Nelson Damale; Brian Cox Journal: Ghana Med J Date: 2018-06
Authors: Jonah Musa; Chad J Achenbach; Charlesnika T Evans; Neil Jordan; Patrick H Daru; Olugbenga Silas; Atiene S Sagay; Rose Anorlu; Supriya D Mehta; Firas Wehbe; Melissa A Simon; Isaac F Adewole; Lifang Hou; Robert L Murphy Journal: Infect Agent Cancer Date: 2019-11-29 Impact factor: 2.965
Authors: Francis Adumata Asamoah; Joel Yarney; Aba Scott; Verna Vanderpuye; Zhigang Yuan; Daniel C Fernandez; Michael E Montejo; Mervin Agyeman; Samuel Ntiamoah Boateng; Kwabena Anarfi; Charles Aidoo; Mian M Shahzad; Jing-Yi Chern; Hye-Sook Chon; Robert M Wenham; Kosj Yamoah; Kamran A Ahmed Journal: JCO Glob Oncol Date: 2020-10